Platform showcase — live registry figures, the node map and the provenance record
Documentation

Reference

Data dictionary

All 629 fields of the TIGER eCRF, with their keys, types and allowed values. Field definitions only — no patient data appears on this page.

The nine sections

The eCRF is organised into nine sections. The section a field belongs to determines where its value is stored on the patient record, which import file it should appear in, and which completeness indicator it contributes to.

SectionFieldsWhat it covers
Demographics35Study number, demographic details and comorbidity checklist.
Diagnostics & Staging30Diagnostic work-up, tumour location, clinical staging (AJCC/UICC 8th), neoadjuvant therapy and re-staging.
Surgery14Operative approach, conversion, reconstruction and intra-operative details.
LN Regions44Clinical and pathological detail per lymph-node region (cervical/supraclavicular, upper thoracic, lower thoracic, abdominal).
LN Stations451The same clinical/pathological detail resolved to individual numbered lymph-node stations.
Pathology20Resection specimen findings, pathological staging and margins.
Complications13Post-operative complications and their severity.
Adjuvant6Adjuvant therapy given after resection.
Follow-up16Follow-up status, recurrence and survival status.

The two lymph-node sections account for most of the field count because the form asks the same short battery of questions — clinically positive, count of positive nodes, histologically confirmed, nodes removed, and so on — separately for every region and every numbered station. That is why the table below is searchable rather than printed in full: search for a station number, or filter to one section, rather than scrolling.

Reading an entry

Each row of the table below gives you:

  • Field label — the wording shown on the form, with the form's own help text beneath it where one exists, and the group the field sits in (for example the specific lymph-node station).
  • Key — the identifier used everywhere else: the column header in the import template, the property name inside the record, and the name you will see in a validation flag or an export column.
  • Type — how a value is interpreted on import. choice and choice + other match against a fixed vocabulary (the second also allows a free-text write-in); boolean is a tick box; number and range are numeric, often with a minimum and maximum; date is a date; text is free text; image choice is a diagram the investigator clicks.
  • Required — whether the original form marked the field mandatory. Twenty-one fields are marked required. The importer does not enforce these. The mark is a property of the form definition shown here; the schema the importer validates against currently marks no field required, so an upload missing all twenty-one raises no flag. Treat the column as a statement about the form, not a guarantee about the data.
  • Options / range — the allowed values, collapsed; expand to see the list. For numeric fields, the permitted minimum and maximum and the unit are shown instead.

Free-text write-ins are the identifiability risk

364 of the 629 fields offer a free-text “other” box beside their fixed options. Nothing in the schema stops a name, a hospital number or a date being typed into one. Use the coded options wherever they fit, and never put a direct identifier in a write-in.

Browse the fields

Search matches labels, keys, groups and option values. Filters and sorting run entirely in your browser.

Showing 60 of 629 fields

DemographicsUnique study numberAnonymized study numberStudy identifierunique_idtextRequired—
DemographicsGenderDemographic detailsgenderchoiceRequired
2 options▸
  • Male
  • Female
DemographicsAgeAge in years (At the time of treatment: Positive interval in years from birth to start of first treatment)Demographic detailsagenumberRequiredmin 18, max 99 (Years)
DemographicsHeightHeight in Centimeters at the time of treatmentDemographic detailsheightnumberOptionalmin 90, max 210 (Cm)
DemographicsWeightWeight in Kilograms at the time of treatmentDemographic detailsweightnumberOptionalmin 25, max 250 (Kg)
DemographicsWeight lossDemographic detailsweight_losschoiceOptional
7 options▸
  • None
  • ≤ 2 Kg
  • 2.1 to 5 Kg
  • 5.1 to 10 Kg
  • 10.1 to 20 Kg
  • > 20 Kg
  • Unknown
DemographicsCountry of originDemographic detailscountry_of_originselectOptional
258 options▸
  • Netherlands
  • United Kingdom
  • United States
  • Argentina
  • Australia
  • Austria
  • Bangladesh
  • Belgium
  • Brazil
  • Bulgaria
  • Canada
  • China
  • Denmark
  • Egypt
  • France
  • Germany
  • Greece
  • Hong Kong SAR China
  • Hungary
  • India
  • Ireland
  • Israel
  • Italy
  • Japan
  • Malaysia
  • Nigeria
  • North Korea
  • Norway
  • Poland
  • Singapore
  • South Africa
  • South Korea
  • Spain
  • Sri Lanka
  • Switzerland
  • Sweden
  • Thailand
  • Turkey
  • Afghanistan
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua and Barbuda
  • Armenia
  • Aruba
  • Ascension Island
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Barbados
  • Belarus
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canary Islands
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Ceuta and Melilla
  • Chad
  • Chile
  • Christmas Island
  • Clipperton Island
  • Cocos [Keeling] Islands
  • Colombia
  • Comoros
  • Congo - Brazzaville
  • Congo - Kinshasa
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Côte d’Ivoire
  • Diego Garcia
  • Djibouti
  • Dominica
  • Dominican Republic
  • Ecuador
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Ghana
  • Gibraltar
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and McDonald Islands
  • Honduras
  • Iceland
  • Indonesia
  • Iran
  • Iraq
  • Isle of Man
  • Jamaica
  • Jersey
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau SAR China
  • Macedonia
  • Madagascar
  • Malawi
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar [Burma]
  • Namibia
  • Nauru
  • Nepal
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Oman
  • Outlying Oceania
  • Pakistan
  • Palau
  • Palestinian Territories
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Portugal
  • Puerto Rico
  • Qatar
  • Romania
  • Russia
  • Rwanda
  • Réunion
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Georgia and the South Sandwich Islands
  • South Sudan
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Syria
  • São Tomé and Príncipe
  • Taiwan
  • Tajikistan
  • Tanzania
  • Timor-Leste
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tristan da Cunha
  • Tunisia
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • U.S. Outlying Islands
  • U.S. Virgin Islands
  • Uganda
  • Ukraine
  • United Arab Emirates
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Wallis and Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
  • Åland Islands
DemographicsEthnicityAsian : A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. Black : A person having origins in any of the black racial groups of Africa. Hispanic or Latino : A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. The term, "Spanish origin", can be used in addition to "Hispanic or Latino" White : A person having origins in any of the original peoples of Europe, the Middle East, or North Africa.Demographic detailsethnicitychoiceOptional
6 options▸
  • Asian
  • Black
  • Hispanic / Latino
  • White
  • Others
  • Unknown
DemographicsSmoking historyDemographic detailssmoking_historychoiceRequired
4 options▸
  • Current smoker
  • Former smoker
  • Never smoker
  • Unknown
DemographicsWHO / ECOG Performance Zubrod ScoreDemographic detailswho_ecog_performance_statuschoiceRequired
6 options▸
  • PS 0
  • PS 1
  • PS 2
  • PS 3
  • PS 4
  • Unknown
DemographicsASA Health status scoreASA 1: A normal healthy patient. Example: Fit, non-obese (BMI under 30), a nonsmoking patient with good exercise tolerance. ASA 2: A patient with a mild systemic disease. Example: Patient with no functional limitations and a well-controlled disease (e.g., treated hypertension, obesity with BMI under 35, frequent social drinker or is a cigarette smoker). ASA 3: A patient with a severe systemic disease that is not life-threatening. Example: Patient with some functional limitation as a result of disease (e.g., poorly treated hypertension or diabetes, morbid obesity, chronic renal failure, a bronchospastic disease with intermittent exacerbation, stable angina, and implanted pacemaker). ASA 4: A patient with a severe systemic disease that is a constant threat to life. Example: Patient with functional limitation from severe, life-threatening disease (e.g., unstable angina, poorly controlled COPD, symptomatic CHF, recent (less than three months ago) myocardial infarction or stroke. ASA 5: A moribund patient who is not expected to survive without the operation. The patient is not expected to survive beyond the next 24 hours without surgery. Examples: ruptured abdominal aortic aneurysm, massive trauma, and extensive intracranial hemorrhage with mass effect. The latest version of the American Society of Anesthesiologists (ASA) physical status classification system (ASAPS) as approved by the ASA House of Delegates on October 15, 2014 and adapted for this presentation. Note that there is no specific classification assigned to patients with a moderate systemic disease, just assignments for patients with mild systemic disease (ASA 2) and those with severe systemic disease (ASA 3). Abbreviations used: ASA: American Society of Anesthesiologists, BMI: body mass Index, CHF: congestive heart failure, COPD: chronic obstructive pulmonary disease.Demographic detailsasa_health_status_scorechoiceRequired
6 options▸
  • ASA 1
  • ASA 2
  • ASA 3
  • ASA 4
  • ASA 5
  • Unknown
DemographicsDiabetes MellitusComorbiditiesdiabetes_mellitusbooleanOptional—
DemographicsDiabetes typeComorbiditiesdiabetes_typechoiceOptional
2 options▸
  • Non-insulin-dependent (type II) diabetes mellitus
  • Insulin-dependent (type I) diabetes mellitus
DemographicsDiabetes severityComorbiditiesdiabetes_severitychoiceOptional
2 options▸
  • Uncomplicated diabetes
  • Diabetes with end organ damage
DemographicsRenal function impairmentComorbiditiesrenal_function_impairmentbooleanOptional—
DemographicsRenal disease severityComorbiditiesrenal_disease_severitychoiceOptional
2 options▸
  • Mild renal disease - (Not require treatment)
  • Moderate to severe renal disease - ( Serum creatinine levels >3mg/dl or 265 umol/l , on dialysis, renal transplant, uremeia)
DemographicsLiver diseaseComorbiditiesliver_diseasebooleanOptional—
DemographicsLiver disease severityComorbiditiesliver_disease_severitychoiceOptional
2 options▸
  • Mild liver disease
  • Moderate to severe liver disease
DemographicsCoronary artery / Ischemic heart diseaseComorbiditiescoronary_artery_ischemic_heart_diseasebooleanOptional—
DemographicsSolid tumor presentIncluding the current malignancy treated if clinical stage ≥ T1. Other currently present (or with in the last 5 years) solid tumor without metastasisComorbiditiessolid_tumor_presentbooleanOptional—
DemographicsCOPDCOPD - Chronic obstructive pulmonary diseaseComorbiditiescopdbooleanOptional—
DemographicsHemiplegiaComorbiditieshemiplegiabooleanOptional—
DemographicsConnective tissue diseaseComorbiditiesconnective_tissue_diseasebooleanOptional—
DemographicsCerebrovascular diseaseCVA with mild or no residua or TIAComorbiditiescerebrovascular_diseasebooleanOptional—
DemographicsCongestive heart failureComorbiditiescongestive_heart_failurebooleanOptional—
DemographicsHypertensionComorbiditieshypertensionbooleanOptional—
DemographicsDementiaComorbiditiesdementiabooleanOptional—
DemographicsLeukemia(acute or chronic lukemia)ComorbiditiesleukemiabooleanOptional—
DemographicsMetastatic solid tumorComorbiditiesmetastatic_solid_tumorbooleanOptional—
DemographicsAIDS (not just HIV positive)Comorbiditiesaids_not_just_hiv_positive_booleanOptional—
DemographicsMyocardial infarction(History of myocardial infarction, not ECG changes only)Comorbiditiesmyocardial_infarctionbooleanOptional—
DemographicsPeripheral vascular disease(includes aortic aneurysm >= 6 cm)Comorbiditiesperipheral_vascular_diseasebooleanOptional—
DemographicsArrhythmiaComorbiditiesarrhythmiabooleanOptional—
DemographicsLymphomaComorbiditieslymphomabooleanOptional—
DemographicsPeptic ulcer diseaseComorbiditiespeptic_ulcer_diseasebooleanOptional—
Diagnostics & StagingDate of diagnosisDiagnostic workupsdate_of_diagnosisdateOptional—
Diagnostics & StagingEndoscopy with biopsiesDiagnostic workupsendoscopy_with_biopsiesbooleanOptional—
Diagnostics & Staging(FNA - EUS/EBUS/Other) Fine needle aspiration of lymph nodesDiagnostic workupsfna_eus_ebus_other_fine_needle_aspiration_of_lymph_nodesbooleanOptional—
Diagnostics & StagingEUS Only (no FNA for lymph nodes)Diagnostic workupseus_only_no_fna_for_lymph_nodesbooleanOptional—
Diagnostics & Staging(USG) Ultrasonography for neckDiagnostic workupsultrasonography_for_neckbooleanOptional—
Diagnostics & StagingCT neck/thorax/abdomenDiagnostic workupsct_neck_thorax_abdomenbooleanOptional—
Diagnostics & StagingPET- CT(diagnosis/staging workup)Diagnostic workupspet_ct_diagnosis_stagingbooleanOptional—
Diagnostics & StagingLaparoscopy (diagnosis/staging work up)Diagnostic workupslaparoscopy_diagnosis_staging_work_upbooleanOptional—
Diagnostics & StagingNeoadjuvant therapy used?Neoadjuvant therapyneoadjuvant_therapy_usedchoiceRequired
2 options▸
  • Yes
  • No
Diagnostics & StagingNeoadjuvant therapy start dateNeoadjuvant therapyneoadjuvant_therapy_start_datedateOptional—
Diagnostics & StagingNeoadjuvant therapy end dateNeoadjuvant therapyneoadjuvant_therapy_end_datedateOptional—
Diagnostics & StagingPlanned neoadjuvent regimen/dose completed?Neoadjuvant therapyplanned_neoadjuvent_regimen_dose_completedchoiceOptional
3 options▸
  • Yes
  • No
  • Unknown
Diagnostics & StagingNeoadjuvant therapy type receivedNeoadjuvant therapyneoadjuvant_therapy_type_receivedchoiceOptional
3 options▸
  • Combination chemoradiotherapy
  • Chemotherapy alone
  • Radiotherapy alone
Diagnostics & StagingPlanning image of radiation fieldNeoadjuvant therapyplanning_image_of_radiation_fieldchoiceOptional
3 options▸
  • Axial (2D)
  • Coronal and Sagittal (3D)
  • Unknown
Diagnostics & StagingChemo or chemoradiotherapy regimenNeoadjuvant therapychemo_or_chemoradiotherapy_regimenchoice + otherOptional
8 options + other▸
  • CROSS - Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study
  • MAGIC - Medical Research Council Adjuvant Gastric Infusional Chemotherapy trial
  • FLOT - Chemotherapy using (5FU/leucovorin, Folinic acid, Oxaliplatin, Docetaxel)
  • ECF - Chemotherapy using (Epirubicin–Cisplatin–Fluorouracil)
  • FOLFOX - Folinic acid (also called leucovorin), Fluorouracil (5FU), Oxaliplatin
  • Others / Unknown - Patient received neoadjuvant therapy but the regimen not known
  • DCF - Chemotherapy using (Docetaxel–Cisplatin–Fluorouracil)
  • Definitive Chemoradiotherapy - No intention for surgery
Diagnostics & StagingCT neck, thorax, abdomen for restagingRe-staging investigationsct_neck_thorax_abdomen_for_stagingchoiceOptional
3 options▸
  • Yes
  • No
  • Unknown
Diagnostics & StagingPET - CT for restagingRe-staging investigationspet_ct_for_restagingchoiceOptional
3 options▸
  • Yes
  • No
  • Unknown
Diagnostics & StagingEUS for restagingEndoscopic ultrasound for restaging with or without biopsyRe-staging investigationseus_for_restagingchoiceOptional
3 options▸
  • Yes
  • No
  • Unkown
Diagnostics & StagingcT StageTX - Primary tumor cannot be assessed T0 - No evidence of primary tumor Tis - High-grade dysplasia T1 - Tumor invades lamina propria, muscularis mucosae, or submucosa T1a - Tumor invades lamina propria or muscularis mucosae T1b - Tumor invades submucosa T2 - Tumor invades muscularis propria T3 - Tumor invades adventitia T4 - Tumor invades adjacent structures T4a - Resectable tumor invading pleura, pericardium,or diaphragm T4b - Unresectable tumor invading other adjacent structures, such as aorta, vertebral body, trachea, etc.Clinical staging according to the 8th edition of the AJCC/UICCctchoiceRequired
7 options▸
  • Tx
  • Tis
  • T1
  • T2
  • T3
  • T4a
  • T4b
Diagnostics & StagingcN StageClinical staging according to the 8th edition of the AJCC/UICCcnchoiceRequired
5 options▸
  • (Nx) Not applicable
  • (N0) No regional lymph node metastases
  • (N1) 1 to 2 positive regional lymph nodes
  • (N2) 3 to 6 positive regional lymph nodes
  • (N3) ≥7 positive regional lymph nodes
Diagnostics & StagingcM StageClinical staging according to the 8th edition of the AJCC/UICCcmchoiceRequired
2 options▸
  • (M0) No distant metastases
  • (M1) Distant metastases
Diagnostics & StagingTumor locationCervical 15-20 cm from incisors Upper thoracic 20–25 cm from incisors Middle thoracic >25 to 30 cm from incisors Lower thoracic >30 to 40 cm from incisors Esophagogastric junction Cancers involving the esophagogastricjunction (EGJ) whose epicenteris within the proximal 2 cm of the cardia are to be staged as oesophageal Cancers with epicentermore than 2 cm distal from the EGJ will be staged using the Stomach Cancer TNM and Stage even if the EGJ is involved.Location of the tumortumor_locationchoiceRequired
5 options▸
  • Cervical
  • Upper 3rd
  • Middle 3rd
  • Lower 3rd
  • At the EG junction
Diagnostics & StagingUpper marginProximal / upper margin of the tumorLocation of the tumorupper_marginrangeOptionalmin 1, max 50 (Cm)
Diagnostics & StagingUpper margin unkownLocation of the tumorupper_margin_unkownbooleanOptional—
Diagnostics & StagingLower marginLower / distal margin of tumorLocation of the tumorlower_marginrangeOptionalmin 1, max 50 (Cm)

How fields are stored

Field values are stored per section rather than as one flat row, and most sections are encrypted at rest. Three details are worth knowing if you work with exports or the API:

  • Adjuvant is a real section but shares storage. The adjuvant fields are a section of the form and are read and written as one, but their values live inside the pathology blob. This is deliberate: the record's completion percentage is calculated over a fixed set of eight sections, and adding a ninth would have silently dropped every existing record below 100 % and could have un-completed already verified records.
  • Lymph-node regions are not encrypted. Region-level node data is stored in a plain column because it carries no identifying content; the numbered station data is encrypted like the clinical sections.
  • Some fields are mirrored into plaintext columns. A small set of clinical values — tumour type, location and histology, stage components, surgical approach, node counts and ratio, complication grade and count, the mortality flags, resection margin, follow-up months, recurrence and vital status — are copied out of the encrypted sections into plaintext columns when a record is saved. Those columns are what the analytics read, and they are the columns you get in a non-PHI export. Everything else stays inside the encrypted section.

The importer maps to exactly these field keys, so a column headed with a key from this dictionary lands in the right section automatically. See Data import for how values are coerced and validated against the types and options listed here.

Provenance

This dictionary is generated, not written by hand. It is derived from migration/drupal-reference/tiger-ecrf-elements.yaml — the element export of the study's original Drupal form — by scripts/gen-ecrf-dictionary.py, and the generated file is committed alongside the site so this page and the running platform cannot drift apart unnoticed.

The generator also cross-checks every field's section against the backend's import target schema and refuses to write the file if the two disagree, so the section shown here is the section the importer will actually use.

Definitions only

Field definitions only — widget type, label, options and ranges. No patient data and no institution data are present. Option lists are the values the form offers, not values observed in any record.